Skip to main content

Advertisement

SpringerLink
Log in

Visual Impairments in Parkinson’s Disease

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

Parkinson’s disease (PD) is a slowly progressive neurodegenerative disease in which the main symptoms are movement disorders (bradykinesia, rigidity, resting tremor, and postural instability). However, continuing research into the disease identifies ever more new (non-motor) symptoms. This article discusses visual impairments occurring in PD patients, the pathogenetic mechanisms underlying them, and methods for their correction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Borm, C. D. J. M., Werkmann, M., Graaf, D., et al., “Undetected ophthalmological disorders in Parkinson’s disease,” J. Neurol., 269, No. 7, 1–12 (2022), https://doi.org/10.1007/s00415-022-11014-0.

    Article  Google Scholar 

  2. Somov, E. E. and Obodov, V. A., Lacrimal Dysfunction Syndromes, Chelovek, St. Petersburg (2011).

  3. Edman, M. C., Janga, S. R., Kakan, S. S., et al., “Tears – more to them than meets the eye: why tears are a good source of biomarkers in Parkinson’s disease,” Biomark. Med., 14, No. 2, 151–163 (2020), https://doi.org/10.2217/bmm-2019-0364.

    Article  CAS  PubMed  Google Scholar 

  4. Chen, Z., Li, G., and Liu, J., “Autonomic dysfunction in Parkinson’s disease: Implications for pathophysiology, diagnosis, and treatment,” Neurobiol. Dis., 134, 104700 (2019), https://doi.org/10.1016/j.nbd.2019.104700.

    Article  PubMed  Google Scholar 

  5. Ulusoy, E. K. and Ulusoy, D. M., “Evaluation of corneal sublayers thickness and corneal parameters in patients with Parkinson’s disease,” Int. J. Neurosci., 131, No. 10, 939–945 (2021), https://doi.org/10.1080/00207454.2020.1761353.

    Article  PubMed  Google Scholar 

  6. Roda, M., Ciavarella, C., Giannaccare, G., and Versura, P., “Biomarkers in tears and ocular surface: a window for neurodegenerative diseases,” Eye Contact Lens, 46, S129–S134 (2020), https://doi.org/10.1097/ICL.0000000000000663.

    Article  PubMed  Google Scholar 

  7. Ekker, M. S., Janssen, S., Seppi, K., et al., “Ocular and visual disorders in Parkinson’s disease: common but frequently overlooked,” Parkinsonism Relat. Disord., 40, 1–10 (2017), https://doi.org/10.1016/j.parkreldis.2017.02.014.

    Article  PubMed  Google Scholar 

  8. Wang, M. T. M., Tien, L., Han, A., et al., “Impact of blinking on ocular surface and tear film parameters,” Ocul. Surf., 16, No. 4, 424–429 (2020), https://doi.org/10.1016/j.jtos.2018.06.001.

    Article  Google Scholar 

  9. Avetisova, S. E., Egorova, E. A., and Moshetova, L. K., et al., Ophthalmology. National Guidelines, FEOTAR-Media, Moscow (2019), 2nd ed.

  10. Brzhevskii, V. V., Diagnosis and Treatment of Dry Eye Syndrome, St. Petersburg State Pediatric Medical Academy (1998).

  11. Savitt, J. and Aouchiche, R., “Management of visual dysfunction in patients with Parkinson’s disease,” J. Parkinsons Dis., 10, s1, S49–S56 (2020), https://doi.org/10.3233/JPD-202103.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Savitt, J. and Mathews, M., “Treatment of visual disorders in Parkinson disease,” Curr. Treat. Options Neurol., 20, No. 8, 30 (2018), https://doi.org/10.1007/s11940-018-0519-0.

  13. Rouen, P. A. and White, M. L., “Dry eye disease: prevalence, assessment, and management,” Home Healthc. Now, 36, No. 2, 74–83 (2018), https://doi.org/10.1097/NHH.0000000000000652.

    Article  PubMed  Google Scholar 

  14. Borm, C. D. J. M., Smilowska, K., de Vries, N. M., et al., “The neuro-ophthalmological assessment in Parkinson’s disease,” J. Parkinsons Dis., 9, No. 2, 427–435 (2019), https://doi.org/10.3233/JPD-181523.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Levin, O. S. and Fedorova, N. V., Parkinson’s Disease, MEDpressinform, Moscow (2015), 5th ed.

  16. Veys, L., Vandenabeele, M., Ortuno-Lizaran, I., et al., “Retinal alpha-synuclein deposits in Parkinson’s disease patients and animal models,” Acta Neuropathol., 137, No. 3, 379–395 (2019), https://doi.org/10.1007/s00401-018-01956-z.

    Article  CAS  PubMed  Google Scholar 

  17. Ortuno-Lizaran, I., Beach, T. G., Serrano, G. E., et al., “Phosphorylated α-synuclein in the retina is a biomarker of Parkinson’s disease pathology severity,” Mov. Disord., 33, No. 8, 1315–1324 (2018), https://doi.org/10.1002/mds.27392.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Bodis-Wollner, I., Kozlowsi, P. B., Glazman, S., and Miri, S., “α-synuclein in the inner retina in Parkinson disease,” Ann. Neurol., 75, No. 6, 964–966 (2014), https://doi.org/10.1002/ana.24182.

    Article  CAS  PubMed  Google Scholar 

  19. Beach, T. G., Carew, J., Serrano, G., et al., “Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson’s disease subjects,” Neurosci. Lett., 571, 34–38 (2014), https://doi.org/10.1016/j.neulet.2014.04.027.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Schapansky, J., Nardozzi, J. D., and LaVoie, M. J., “The complex relationships between microglia, α-synuclein and LRRK2 in Parkinson’s disease,” Neuroscience, 302, 74–88 (2015), https://doi.org/10.1016/j.neuroscience.2014.09.049.

    Article  CAS  PubMed  Google Scholar 

  21. Scheiblich, H., Dansokho, C., Mercan, D., et al., “Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes,” Cell, 184, No. 20, 5089–5106.e21 (2021), https://doi.org/10.1016/j.cell.2021.09.007.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Ramirez, A. I., de Hoz, R., Salobrar-Gracia, E., et al., “The role of microglia in retinal neurodegeneration: Alzgeimer’s disease, Parkinson, and glaucoma,” Front. Aging Neurosci., 9, 214 (2017), https://doi.org/10.3389/fnagi.2017.00214.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Miri, S., Glazman, S., Mylin, L., and Bodis-Wollner, I., “A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson’s disease,” Parkinsonism Relat. Disord., 22, S134–S137 (2016), https://doi.org/10.1016/j.parkreldis.2015.09.015.

    Article  PubMed  Google Scholar 

  24. Perez-Fernandez, V., Milosavljevic, N., Allen, A. E., et al., “Rod photoreceptor activation alone defines the release of dopamine in the retina,” Curr. Biol., 29, No. 5, 763–774.e5 (2019), https://doi.org/10.1016/j.cub.2019.01.042.

    Article  CAS  PubMed  Google Scholar 

  25. Jackson, C. R., Ruan, G. X., Aseem, F., et al., “Retinal dopamine mediates multiple dimensions of light-adapted vision,” J. Neurosci., 32, No. 27, 9359–9368 (2012), https://doi.org/10.1523/JNEUROSCI.0711-12.2012.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Marrocco, E., Esposito, F., Tarallo, V., et al., “α-synuclein in the retina leads to degeneration of dopamine amacrine cells impairing vision,” BioRxiv, 760603 (2019), https://doi.org/10.1101/760603.

  27. La Morgia, C., Ross-Cisneros, F. N., Sadun, A. A., and Carelli, V., “Retinal ganglion cells and circadian rhythms in Alzheimer’s disease, Parkinson’s disease and beyond,” Front. Neurol., 8, 162 (2017), https://doi.org/10.3389/fneur.2017.00162.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Vuong, H. E., Hardi, C. N., Barnes, S., and Brecha, N. C., “Parallel inhibition of dopamine amacrine cells and intrinsically photosensitive retinal ganglion cells in a non-image-forming visual circuit of mouse retina,” J. Neurosci., 35, No. 48, 15955–15970 (2015), https://doi.org/10.1523/JNEUROSCI.3382-15.2015.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Ortuno-Lizaran, I., Esquiva, G., Beach, T. G., et al., “Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson’s disease,” Acta Neuropathol. Comm., 6, No. 1, 1–10 (2018), https://doi.org/10.1186/s40478-018-0596-z.

    Article  CAS  Google Scholar 

  30. Munteanu, T., Noronha, K. J., Leung, A. C., et al., “Light-dependent pathways for dopaminergic amacrine cells development and function,” eLife, 7, e39866 (2018), https://doi.org/10.7554/eLife.39866.

  31. Miri, S., Glazman, S., and Bodis-Wollner, I., “OCT and Parkinson’s disease,” OCT in Central Nervous System Diseases (2016), pp. 105–121, https://doi.org/10.1007/978-3-319-24085-5_6.

  32. Chrysou, A., Jansonius, N. M., and van Laar, T., “Retinal layers in Parkinson’s disease: A meta-analysis of spectral-domain optical coherence tomography studies,” Parkinsonism Relat. Disord., 64, 40–49 (2019), https://doi.org/10.1016/j.parkreldis.2019.04.023.

    Article  PubMed  Google Scholar 

  33. Pilat, A., McLean, R. J., Proudlock, F. A., et al., “In vivo morphology of optic nerve and retina in patients with Parkinson’s disease,” Invest. Ophthalmol. Vis. Sci., 57, No. 10, 4420–4427 (2016), https://doi.org/10.1167/iovs.16-20020.

    Article  PubMed  Google Scholar 

  34. Egorova, E. A., Glaucoma. National Guidelines, GEOTAR-Media, Moscow (2013).

  35. Kaur, M., Saxena, R., Singh, D., et al., “Correlation between structural and functional retinal changes in Parkinson disease,” J. Neuroophthamol., 35, No. 3, 254–258 (2015), https://doi.org/10.1097/WNO.0000000000000240.

    Article  Google Scholar 

  36. Ahn, J., Lee, J. Y., Kim, T. W., et al., “Retinal thinning associates with nigral dopaminergic loss in de novo Parkinson disease,” Neurology, 91, No. 11, e1003–e1012 (2018), https://doi.org/10.1212/WNL.0000000000006157.

    Article  CAS  PubMed  Google Scholar 

  37. Lee, J. J., Shin, N. Y., Lee, Y., et al., “Optic nerve integrity as a visuospatial cognitive predictor in Parkinson’s disease,” Parkinsonism Relat. Disord., 31, 41–45 (2016), https://doi.org/10.1016/j.parkreldis.2016.06.020.

    Article  PubMed  Google Scholar 

  38. Lee, J. Y., Ahn, J., Yoon, E. J., et al., “Macular ganglion-cell-complex layer thinning and optic nerve integrity in drug-naïve Parkinson’s disease,” J. Neural Transm. (Vienna), 126, No. 12, 1695–1699 (2019), https://doi.org/10.1007/s00702-019-02097-7.

    Article  PubMed  Google Scholar 

  39. Arrigo, A., Calamuneri, A., Milardi, D., et al., “Visual system involvement in patients with newly diagnosed Parkinson disease,” Radiology, 285, No. 3, 885–895 (2017), https://doi.org/10.1148/radiol.2017161732.

    Article  PubMed  Google Scholar 

  40. Ridder, A., Muller, M. L. T. M., Kotagal, V., et al., “Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease,” Parkinsonism Relat. Disord., 34, 15–19 (2017), https://doi.org/10.1016/j.parkreldis.2016.10.006.

    Article  CAS  PubMed  Google Scholar 

  41. Anang, J. B. M., Gagnon, J. F., Bertrand, J. A., et al., “Predictors of dementia in Parkinson’s disease: A prospective cohort study,” Neurology, 83, No. 14, 1253–1260 (2014), https://doi.org/10.1212/WNL.0000000000000842.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Murueta-Goyena, A., Del Pino, R., Galdós, M., et al., “Retinal thickness predicts the risk of cognitive decline in Parkinson disease,” Ann. Neurol., 89, No. 1, 165–176 (2021), https://doi.org/10.1002/ana.25944.

    Article  CAS  PubMed  Google Scholar 

  43. Leyland, L.-A., Bremner, F. D., Mahmood, R., et al., “Visual tests predict dementia risk in Parkinson disease,” Neurol. Clin. Pract., 10, No. 1, 29–39 (2020), https://doi.org/10.1212/CPJ.0000000000000719.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Weil, R. S., Schrag, A. E., Warren, J. D., et al., “Visual dysfunction in Parkinson’s disease,” Brain, 139, No. 11, 2827–2843 (2016), https://doi.org/10.1093/brain/aww175.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Bohnen, N. I., Koeppe, R. A., Minoshima, S., et al., “Cerebral glucose metabolic features of Parkinson’s disease and incident dementia: longitudinal study,” J. Nucl. Med., 52, No. 6, 858–855 (2011), https://doi.org/10.2967/jnumed.111.089946.

    Article  CAS  Google Scholar 

  46. Lenka, A., Jhunjhunwala, K. R., Saini, J., and Pal, P. K., “Structural and functional neuroimaging in patients with Parkinson’s disease and visual hallucinations: A critical review,” Parkinsonism Relat. Disord., 21, No. 7, 683–691 (2015), https://doi.org/10.1016/j.parkreldis.2015.04.005.

    Article  PubMed  Google Scholar 

  47. Barrell, K., Bureau, B., Turcano, P., et al., “High-order visual processing, visual symptoms, and visual hallucinations: A possible symptomatic progression of Parkinson’s disease,” Front. Neurol., 9, 999 (2018), https://doi.org/10.3389/fneur.2018.00999.

    Article  PubMed  PubMed Central  Google Scholar 

  48. O’Callaghan, C., Hall, J. M., Tomassini, A., et al., “Visual hallucinations are characterized by impaired sensory evidence accumulation: insights from hierarchical drift diffusion modeling in Parkinson’s disease,” Biol. Psychiatry Cogn. Neurosci. Neuroimaging, 2, No. 8, 680–688 (2017), https://doi.org/10.1016/j.bpsc.2017.04.007.

    Article  PubMed  Google Scholar 

  49. Pagonabarraga, J., Martinez-Horta, S., de Bobadilla, R. F., et al., “Minor hallucinations occur in drug-naive Parkinson’s disease patients, even from the premotor phase,” Mov. Disord., 31, No. 1, 45–52 (2016), https://doi.org/10.1002/mds.26432.

    Article  PubMed  Google Scholar 

  50. Lenka, A., Pagonabarraga, J., Pal, P. K., et al., “Minor hallucinations in Parkinson’s disease: A subtle symptom with major clinical implications,” Neurology, 93, No. 6, 259–266 (2019), https://doi.org/10.1212/WNL.0000000000007913.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Lee, W.-W., Yoon, E. J., Lee, J.-Y., et al., “Visual hallucinations and pattern of brain degeneration in Parkinson’s disease,” Neurodegener. Dis., 17, No. 2–3, 62–72 (2017), https://doi.org/10.1159/000448517.

    Article  Google Scholar 

  52. Aarsland, D., Batzu, L., Halliday, G. M., et al., “Parkinson disease-associated cognitive impairment,” Nat. Rev. Dis. Primers, 7, No. 1, 1–21 (2021), https://doi.org/10.1038/s41572-021-00280-3.

    Article  Google Scholar 

  53. Hermanowicz, N. and Edwards, K., “Parkinson’s disease psychosis: symptoms, management, and economic burden,” Am. J. Manag. Care, 21, No. 10, Supplement, s199–s206 (2015).

Download references

Author information

Authors and Affiliations

  1. Russian Medical Academy for Continuing Professional Education, Russian Ministry of Health, Moscow, Russia

    A. Yu. Nikitina, N. V. Melnikova, L. K. Moshetova & O. S. Levin

Authors
  1. A. Yu. Nikitina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. V. Melnikova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. K. Moshetova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O. S. Levin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Yu. Nikitina.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 122, No. 11, Iss. 2, pp. 5–11, November, 2022.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nikitina, A.Y., Melnikova, N.V., Moshetova, L.K. et al. Visual Impairments in Parkinson’s Disease. Neurosci Behav Physi 53, 952–958 (2023). https://doi.org/10.1007/s11055-023-01487-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-023-01487-5

Keywords

Search

Navigation